Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Century City Psychiatry Addresses Kratom and 7-OH Dependence With Specialized Outpatient Care

Century City Psychiatry

News provided by

Century City Psychiatry

Oct 09, 2026, 12:02 ET

Share this article

Share toX

Share this article

Share toX

Century City Psychiatry, a physician-owned outpatient psychiatry practice in Los Angeles, offers specialized, individualized outpatient treatment for adults who want to stop using kratom, kratom extracts, or concentrated 7-hydroxymitragynine (7-OH) products. Developed under the clinical leadership of founder and board-certified psychiatrist Dr. Mike Mah, the program pairs medical support with care for the anxiety, depression, sleep difficulties, and other conditions that often accompany kratom use.

LOS ANGELES, Oct. 9, 2026 /PRNewswire/ -- Century City Psychiatry, a physician-owned outpatient psychiatry practice in Los Angeles, is responding to a growing public-health concern with specialized outpatient care for kratom and 7-OH dependence. The program, described on the practice's Kratom and 7-OH Dependence page, is designed for adults who use traditional leaf kratom, kratom extracts, or concentrated 7-OH tablets, shots, and extracts and are ready to stop.

Continue Reading
Dr. Mike Mah
Dr. Mike Mah

Kratom, the leaf of the Southeast Asian tree Mitragyna speciosa, has been sold in the United States for years as a powder, capsule, or tea. More recently, a different category of product containing concentrated 7-OH has appeared in gas stations, smoke shops, and online stores, often marketed as a natural wellness supplement and frequently without clear labeling of its 7-OH content. Although 7-OH occurs only in trace amounts in the natural leaf, it acts on the same brain receptors as prescription opioids, and people who use concentrated products regularly can develop physical dependence and significant withdrawal symptoms. In July 2026, the U.S. Drug Enforcement Administration announced its intent to temporarily place 7-OH in Schedule I of the Controlled Substances Act, citing the proliferation of concentrated commercial products. The regulatory landscape around these products continues to evolve.

Many people who develop kratom or 7-OH dependence find themselves caught in a gap in care. Addiction-medicine clinics can feel intimidating, residential programs are impractical for working adults, and many general psychiatric practices do not treat substance use disorders. Patients are often surprised to learn what they were taking, and shame about being unable to stop can keep them from asking for help. Century City Psychiatry's program is built to offer a confidential, outpatient alternative that fits into the lives of people with careers and family responsibilities.

The program was developed under the clinical leadership of Dr. Mike Mah, founder and clinical director of Century City Psychiatry. Dr. Mah is board-certified by the American Board of Psychiatry and Neurology, earned his medical degree from UC Irvine, and completed his psychiatry residency at UCLA and the West Los Angeles VA. He designs the practice's treatment protocols and supervises a team of psychiatric nurse practitioners and prescribing clinicians who provide day-to-day patient care.

Each treatment plan is individualized around what a patient is using, how much, and the goals the patient brings to the first visit. Care begins with a comprehensive evaluation of kratom or 7-OH use alongside a full medical and psychiatric history. For patients with moderate to severe dependence, particularly with 7-OH, clinicians may discuss medication support, including buprenorphine, an FDA-approved medication for opioid use disorder, introduced gradually through a micro-induction approach rather than requiring a patient to be in full withdrawal first. For patients using smaller amounts of leaf kratom, a structured taper supported by non-addictive medications may be appropriate. Because severe dependence cannot always be managed safely in an outpatient setting, some patients may need a higher level of care, such as medically supervised detox or residential treatment, and the practice helps coordinate those referrals when needed. Treatment decisions are always made together with a clinician.

Because many patients began using kratom to manage anxiety, depression, ADHD, chronic pain, or poor sleep, treatment of these underlying conditions is a central part of care. The practice coordinates with Los Angeles therapists who specialize in substance use, and most patients continue follow-up care for several months to a year as stability builds. Treatment records are protected under HIPAA and additional federal rules specific to substance use disorder care. As an insurance-based group practice, Century City Psychiatry accepts many major commercial insurance plans, with specific coverage confirmed at intake.

"Most people who develop kratom dependence are not who you picture when you hear the word 'addiction,'" said Dr. Mah. "They are working adults who started using to manage anxiety, pain, or sleep, and many had no idea how strong some of these products had become. Treating those underlying conditions is easy to miss, and it is central to how we built this program. With the right medical support and a thoughtful, gradual start, withdrawal does not have to be something people white-knuckle alone. Reaching out is often the hardest step, and we want patients and their families to know that individualized, confidential care is available."

Information about kratom and 7-OH treatment is educational and is not medical advice. Anyone experiencing a medical emergency should call 911, and anyone in crisis can call or text 988 to reach the Suicide and Crisis Lifeline.

More About Century City Psychiatry

Century City Psychiatry is a physician-owned outpatient psychiatry practice in Los Angeles founded by Dr. Mike Mah, a board-certified psychiatrist who serves as the practice's clinical director. The insurance-based group practice provides psychiatric evaluation, medication management, deprescribing, ongoing psychiatric care, second opinions, and care coordination, with in-person and secure virtual visits available. The practice treats adults with anxiety disorders, mood disorders, ADHD, insomnia, trauma-related conditions, and substance use and dual-diagnosis concerns, including kratom and 7-OH dependence, with an emphasis on evidence-based, physician-directed care.

Century City Psychiatry is located at 10323 Santa Monica Blvd., #108A, Los Angeles, CA 90025. For more information or to schedule a confidential evaluation, please call (310) 340-0089 or visit www.centurycitypsychiatry.com.

Media Contact

Century City Psychiatry
10323 Santa Monica Blvd., #108A, Los Angeles, CA 90025
(310) 340-0089
https://www.centurycitypsychiatry.com

SOURCE Century City Psychiatry

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Century City Psychiatry Expands Focus on Modern, Evidence-Based Mental Health Innovation and Interventional Psychiatry

Century City Psychiatry Expands Focus on Modern, Evidence-Based Mental Health Innovation and Interventional Psychiatry

As mental health care continues to evolve alongside advances in technology, neuroscience, and clinical research, Century City Psychiatry is expanding ...

Los Angeles Psychiatric Practice Century City Psychiatry Announces Major Expansion to Meet Growing Demand for Mental Health Care

Los Angeles Psychiatric Practice Century City Psychiatry Announces Major Expansion to Meet Growing Demand for Mental Health Care

Century City Psychiatry is experiencing a period of significant growth, driven by rising demand for accessible, evidence-based psychiatric care...

More Releases From This Source

Explore

Supplementary Medicine

Supplementary Medicine

Mental Health

Mental Health

Medical Pharmaceuticals

Medical Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.